Clinical Trial Update: Seizure Therapy With Intravenous Levetiracetam and Lorazepam [Phase 2, Phase 3]

View source ↗

Summary

The Phase 2/3 clinical trial evaluating intravenous levetiracetam with lorazepam for seizure therapy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• LEVETIRACETAM (levetiracetam)
• Lorazepam (Lorazepam)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Seizures | Phase 2, Phase 3 | Status: WITHDRAWN